Cargando…
Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
PURPOSE: For patients with triple negative breast cancer (TNBC), the optimal time to initiate neoadjuvant chemotherapy (TTNC) is unknown. This study evaluates the association between TTNC and survival in patients with early TNBC. METHODS: A retrospective study using data from of a cohort of TNBC pat...
Autores principales: | Hatzipanagiotou, Maria Eleni, Pigerl, Miriam, Gerken, Michael, Räpple, Sophie, Zeltner, Verena, Hetterich, Madeleine, Ugocsai, Peter, Fernandez-Pacheco, Miriam, Inwald, Elisabeth Christine, Klinkhammer-Schalke, Monika, Ortmann, Olaf, Seitz, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465651/ https://www.ncbi.nlm.nih.gov/pubmed/37418056 http://dx.doi.org/10.1007/s00432-023-05060-y |
Ejemplares similares
-
Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery
por: Fernández-Pacheco, Miriam, et al.
Publicado: (2022) -
Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients
por: Taubenhansl, Clara, et al.
Publicado: (2019) -
Auswirkungen der COVID-19-Pandemie auf die Inzidenz und Therapie von Krebserkrankungen
por: Inwald, Elisabeth C., et al.
Publicado: (2022) -
The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
por: Brockhoff, Gero, et al.
Publicado: (2017) -
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125
por: Seitz, Stephan, et al.
Publicado: (2014)